Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant® implants

Human Reproduction

Volumn 13, Issue 1, 1998, Pages 188-191

  Faundes A ^a,c   Alvarez, F ^b   Brache, V ^b   Cochon L ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Biomedical Research Department   (Dominican Republic)

^c NONE   (Brazil)

Author keywords

Bleeding irregularities; Endometrial bleeding; Endometrial thickness; Norplant implants; Oestradiol

Indexed keywords

ESTRADIOL; LEVONORGESTREL; PROGESTERONE;

ARTICLE; CORPUS LUTEUM; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; PROGESTERONE BLOOD LEVEL; THICKNESS; TRANSVAGINAL ECHOGRAPHY; UTERUS BLEEDING;

EID: 2642703413     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.1.188     Document Type: Article

References (26)

1. Alvarez, F., Brache, V., Thevenin, F. et al. (1996) Hormonal treatment for bleeding irregularities in Norplant® implant users. Am. J. Obstet. Gynecol., 174, 919-922.
2. Archer, D.F., Philput, C.A. and Weber, M.E. (1996) Management of irregular uterine bleeding and spotting associated with Norplant®. Hum. Reprod., 11, (suppl. 2), 24-30.
3. Au, C.L., Affandi, B. and Rogers, P.A.W. (1994) Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant® implants use. Contraception, 50, 477-489.
4. Bakos, O., Smith, P. and Heimer, G. (1994) Ultrasonographical and hormonal description of the normal ovulatory menstrual cycle. Acta Obstet. Gynecol. Scand., 73, 790-796.
5. Critchley, H.O.D., Bailey, D.A., Au, C.L. et al.(1993) Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Hum. Reprod., 8, 1632-1639.
6. Croxatto, H.D., Diaz, S., Pavez, M. et al. (1984) Histopathology of the endometrium during continuous use of levonorgestrel. In Zatuchni, G.I., Goldsmith, A., Shelton, J.D. et al. (eds). Long-acting Contraceptive Delivery Systems. Harper and Row, Philadelphia, pp. 290-295.
7. Darney, P.D., Taylor, R.N., Klaisle, C. et al. (1996) Serum concentration of oestradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant® implants users. Contraception, 53, 97-100.
8. Diaz, S., Croxatto, H.B., Pavez, M. et al. (1990) Clinical assessment of treatments for prolonged bleeding in users of Norplant® implants. Contraception, 42, 97-109.
9. Faúndes, A., Alvarez-Sanchez, F., Brache, V. et al. (1991) Hormonal changes associated with bleeding during low dose progestogen contraception delivered by Norplant® subdermal implants. Adv. Contracep., 7, 1-10.
10. Fleischer, A.C., Kalemeris, G.C., Machin, J.E. et al. (1986) Sonographic depiction of normal and abnormal endometrium with histopathologic correlation. J. Ultrasound Med., 5, 445-452.
11. Goodger, A.M., Rogers, P.A.W., Affandi, B. (1994) Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel. Hum. Reprod., 9, 1647-1651.
12. Hadisaputra, W., Affandi, B., Witjaksono, J. et al. (1996) Endometrial biopsy collection from women receiving Norplant. Hum. Reprod., 11 (Suppl. 2), 31-34.
13. Hickey, M., Fraser, I.S., Dwarte, D.D. and Graham, S. (1996) Endometrial vasculature in Norplant® users: preliminary results from a hystereoscopic study. Hum. Reprod., 11 (Suppl. 2), 35-44.
14. Janne, O., Isomaa, V., Isotalo, H. et al. (1978) Uterine estrogen and progestin receptors and their regulation. Upsala J. Med. Sci., 22, 62-70.
15. Johannisson, E., Brosens, I., Cornilie, F. et al. (1991) Morphometric study of the human endometrium following continuous exposure to levonorgestrel release from vaginal rings during 90 days. Contraception, 43, 361-374.
16. Luukkainen, T. and Haukkamaa, M. (1990) Concentration of levonorgestrel in endometrium and myometrium after oral and intrauterine administration. In d'Arcangues, C., Fraser, I.S., Newton, J. et al. (eds), Contraception and Mechanisms of Endometrial Bleeding. Cambridge University Press, Cambridge, pp. 181-186.
17. Maqueo, M. (1980) Vascular and perivascular changes in the endometrium of women using steroidal contraceptives. In Diczfalusy, E., Fraser, I.S., Webb, F.T.G. (eds), Endometrial Bleeding and Steroidal Contraception. Pitman Press, London, pp. 138-152.
18. Marsh, M.M., Butt, A.R., Riley, S.C. et al. (1995) Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant®). Hum. Reprod., 10, 2584-2589.
19. Olsson, S.E., Bakos, O., Lindgren, P.G. et al. (1990) Ovarian function during use of subdermal implants releasing low doses of levonorgestrel. Br. J. Fam. Plann., 16, 88-93.
20. Palmer, J.A., Lau, T.M., Hickley, M. et al. (1996) Immunohistochemical study of endometrial microvascular basement membrane components in women using Norplant®. Hum. Reprod., 11, 2142-2150.
21. Rogers, P.A.W., Au, S.L. and Affandi, B. (1993) Endometrial microvascular density during the normal menstrual cycle and following exposure to long term levonorgestrel. Hum. Reprod., 8, 1396-1404.
22. Shaaban, M.M., Segal, S., Salem, H.T. et al. (1993) Sonographic assessment of ovarian and endometrial changes during long-term Norplant® use and their correlation with hormonal concentrations, Fertil. Steril., 59, 998-1002.
23. Subakir, S.B., Hadisaputra, W., Siregar, B. et al. (1995) Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant® contraception. Hum. Reprod., 10, 2579-2583.
24. Witjaksono, J., Lau, T.M., Affandi, B. and Rogers, P.A.W. (1996) Oestrogen treatment for increased bleeding in Norplant® users: preliminary results. Hum. Reprod., 11, 109-114.
25. Wonodirekso, S., Au, C.L., Hadisaputra, W. et al. (1993) Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant®. Contraception, 48, 481-493.
26. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation (1996) Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. Hum. Reprod., 11, 1-13.